Abstract

In this study, bovine serum albumin (BSA) nanoparticles containing resveratrol (RVT) were developed to improve the biopharmaceutical characteristics of the RVT. BSA nanoparticles containing RVT (RVT-NP) were obtained by the coacervation technique and presented mean diameter of 175 ± 6 nm, polydispersity of 0.130 ± 0.01, zeta potential of −37.4 ± 1.3 mV and encapsulation efficiency about 60%. Morphological analysis revealed spherical and smooth nanoparticles. In vitro release profile was prolonged and after 144 h about 26% of RVT were released. The release kinetic followed the second order model, characterized by a rapid initial release followed by a slower RVT release diffusion-controlled. Nanoencapsulation process resulted in RVT amorphization and chemical interactions between RVT and BSA. Nanoparticles were stable over 90 days at room temperature and under refrigeration (2–8 °C). In the hypochlorous acid scavenging activity, RVT-NP presented inferior activity than free RVT, probably due to the prolonged RVT release. Blank BSA nanoparticles also presented scavenging activity, thus, antioxidant activity of RVT-NP was an addition of the effects of the RVT and BSA. Thus, BSA nanoparticles are promising carriers for prolonged RVT release and application in oxidative stress-based diseases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.